Coronavirus (Covid-19). COVID-19, virus identified
Conditions
Interventions
Intervention 1: "Intervention group": In this study, patients with severe type or severity of COVID-19 disease, in addition to other treatments and according to the doctor, had a dose of IVIg treatmen
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Having laboratory and clinical results of COVID-19 Positive PCR test for COVID-19 Do not have other allergic diseases and cancer
Exclusion criteria
Exclusion criteria: Taking any immunosuppressive drugs during treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum sodium level (Na). Timepoint: The day before the intervention and the fourth day after the intervention. Method of measurement: Measurement of sodium in the patient's blood in terms of milliequivalents per liter, before and after treatment until the fourth day after the intervention and comparison of the two groups using a flame photometer.;Potassium (K). Timepoint: The day before the intervention and the fourth day after the intervention. Method of measurement: Measurement of potassium in the patient's blood in milliequivalents per liter, before and after treatment until the fourth day after the intervention and comparison of the two groups using a flame photometer.;AST. Timepoint: The day before the intervention and the fourth day after the intervention. Method of measurement: Assessment of AST enzyme level before intervention and 4 days after comparison with control group using autoanalyzer.;ALT. Timepoint: The day before the intervention and the fourth day after the intervention. Method of measurement: Assessment of ALT enzyme level before intervention and 4 days after comparison with control group using autoanalyzer.;LDH. Timepoint: The day before the intervention and the fourth day after the intervention. Method of measurement: Assessment of LDH enzyme level before intervention and 4 days after comparison with control group using autoanalyzer.;D-dimer. Timepoint: The day before the intervention and the fourth day after the intervention. Method of measurement: Measurement of D-dimer before and 4 days in comparison with the control group using laboratory equipment.;ESR. Timepoint: The day before the intervention and the fourth day after the intervention. Method of measurement: Measurement of ESR before and 4 days compared to the control group using Westergreen method.;CRP. Timepoint: The day before the intervention and the fourth day after the intervention. Method of measurement: Measurement of CRP in patients' serum before and 4 days after the interventio | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactBehrooz Ghezelbash
Esfahan University of Medical Sciences
Outcome results
None listed